• 13166 Citations
  • 40 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

Az emlorák korszeru gyógyszeres kezelése

Láng, I., Kahán, Z., Hitre, E., Dank, M., Rubovszky, G., Horváth, Z. & Kásler, M., jan. 1 2012, In : Orvosi hetilap. 153, 2, p. 56-65 10 p.

Research output: Article

3 Citations (Scopus)

Az emlorák korszeru képalkotó diagnosztikája: nukleárismedicina-technikák

Katalin, B., István, S., Balázs, M., Zsolt, H., István, L. & Miklós, K., jan. 1 2012, In : Orvosi hetilap. 153, 1, p. 14-21 8 p.

Research output: Article

Az emlótumor csontveló mikrometasztázisának klinikai jelentósége.

Dubecz, S., Csuka, O., Török, K., Vasas, N., Péley, G., Doleschal, Z., Sulyok, Z., Láng, I. & Köves, I., aug. 2003, In : Magyar sebészet. 56, 3-4, p. 108-112 5 p.

Research output: Article

1 Citation (Scopus)

Az epeúti carcinomák gyógyszeres kezelé sének lehetõségei. Múlt - Jelen - Jóvo

Gábor, R., Erika, H. & István, L., júl. 24 2013, In : Lege Artis Medicinae. 23, 5-6, p. 255-261 7 p.

Research output: Article

4 Citations (Scopus)

Az indometacin lymphocyta proliferációt fokozó hatása in vivo.

Kalmár, L., Rhenzo, G. C., Láng, I., Gergely, P. & Fehér, J., nov. 24 1985, In : Orvosi hetilap. 126, 47, p. 2889-2893 5 p.

Research output: Article

Az MR-vizsgálat szerepe a rectumcarcinomák terápiájának meghatározásában

Jederán, É., Mátrai, Z., Tóth, L., Lövey, J., Láng, I., Hitre, E., Naszádos, G. & Godény, M., 2012, In : Magyar onkologia. 56, 3, p. 179-186 8 p.

Research output: Article

1 Citation (Scopus)

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): An open-label, randomised phase 3 trial

Cunningham, D., Lang, I., Marcuello, E., Lorusso, V., Ocvirk, J., Shin, D. B., Jonker, D., Osborne, S., Andre, N., Waterkamp, D. & Saunders, M. P., okt. 1 2013, In : The Lancet Oncology. 14, 11, p. 1077-1085 9 p.

Research output: Article

357 Citations (Scopus)

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): An open-label, randomised phase 3 trial

von Minckwitz, G., Puglisi, F., Cortes, J., Vrdoljak, E., Marschner, N., Zielinski, C., Villanueva, C., Romieu, G., Lang, I., Ciruelos, E., De Laurentiis, M., Veyret, C., de Ducla, S., Freudensprung, U., Srock, S. & Gligorov, J., okt. 1 2014, In : The Lancet Oncology. 15, 11, p. 1269-1278 10 p.

Research output: Article

99 Citations (Scopus)

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: Interim efficacy results of the randomised, Open-label, Non-inferiority, Phase 3 TURANDOT trial

Lang, I., Brodowicz, T., Ryvo, L., Kahan, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G. G., Melichar, B., Pienkowski, T., Sirbu, D., Messinger, D. & Zielinski, C., febr. 1 2013, In : The Lancet Oncology. 14, 2, p. 125-133 9 p.

Research output: Article

79 Citations (Scopus)

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial

Zielinski, C., Láng, I., Inbar, M., Kahán, Z., Greil, R., Beslija, S., Stemmer, S. M., Zvirbule, Z., Steger, G. G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenbaum, B., Dank, M., Anghel, R., Messinger, D. & Brodowicz, T., szept. 1 2016, In : The Lancet Oncology. 17, 9, p. 1230-1239 10 p.

Research output: Article

30 Citations (Scopus)

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Rabaglio, M., Sun, Z., Price, K. N., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J. F., Paridaens, R. J., Colleoni, M., Pienkowski, T., Nogaret, J. M., Láng, I., Smith, I., Gelber, R. D., Goldhirsch, A. & Coates, A. S., 2009, In : Annals of Oncology. 20, 9, p. 1489-1498 10 p.

Research output: Article

108 Citations (Scopus)

Bosutinib in combination with the aromatase inhibitor exemestane: A phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer

Moy, B., Neven, P., Lebrun, F., Bellet, M., Xu, B., Sarosiek, T., Chow, L., Goss, P., Zacharchuk, C., Leip, E., Turnbull, K., Bardy-Bouxin, N., Duvillié, L. & Láng, I., 2014, In : Oncologist. 19, 4, p. 346-347 2 p.

Research output: Article

7 Citations (Scopus)

Bosutinib in combination with the aromatase inhibitor letrozole: A phase II trial in postmenopausalwomen evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer

Moy, B., Neven, P., Lebrun, F., Bellet, M., Xu, B., Sarosiek, T., Chow, L., Goss, P., Zacharchuk, C., Leip, E., Turnbull, K., Bardy-Bouxin, N., Duvillié, L. & Láng, I., 2014, In : Oncologist. 19, 4, p. 348-349 2 p.

Research output: Article

14 Citations (Scopus)

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study

Rubovszky, G., Láng, I., Ganofszky, E., Horváth, Z., Juhos, É., Nagy, T., Szabó, E., Szentirmay, Z., Budai, B. & Hitre, E., dec. 1 2013, In : European Journal of Cancer. 49, 18, p. 3806-3812 7 p.

Research output: Article

36 Citations (Scopus)
37 Citations (Scopus)

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Van Cutsem, E., Köhne, C. H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., Schlichting, M., Zubel, A., Celik, I., Rougier, P. & Ciardiello, F., máj. 20 2011, In : Journal of Clinical Oncology. 29, 15, p. 2011-2019 9 p.

Research output: Article

1294 Citations (Scopus)

Characterization of the effector cells in Con A-induced cytotoxicity against HEp 2 tumour targets.

Pócsik, E., González-Cabello, R., Benedek, K., Perl, A., Láng, I. & Gergely, P., dec. 1 1983, In : Acta medica Hungarica. 40, 1, p. 41-46 6 p.

Research output: Article

1 Citation (Scopus)

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): A randomised trial

Aebi, S., Gelber, S., Anderson, S. J., Láng, I., Robidoux, A., Martín, M., Nortier, J. W. R., Paterson, A. H. G., Rimawi, M. F., Cañada, J. M. B., Thürlimann, B., Murray, E., Mamounas, E. P., Geyer, C. E., Price, K. N., Coates, A. S., Gelber, R. D., Rastogi, P., Wolmark, N. & Wapnir, I. L., febr. 2014, In : The Lancet Oncology. 15, 2, p. 156-163 8 p.

Research output: Article

119 Citations (Scopus)

Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study

Borgquist, S., Giobbie-Hurder, A., Ahern, T. P., Garber, J. E., Colleoni, M., Láng, I., Debled, M., Ejlertsen, B., Von Moos, R., Smith, I., Coates, A. S., Goldhirsch, A., Rabaglio, M., Price, K. N., Gelber, R. D., Regan, M. M. & Thürlimann, B., ápr. 10 2017, In : Journal of Clinical Oncology. 35, 11, p. 1179-1188 10 p.

Research output: Article

39 Citations (Scopus)

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: A retrospective substudy of the HERA trial (BIG 1-01)

Pestalozzi, B. C., Holmes, E., de Azambuja, E., Metzger-Filho, O., Hogge, L., Scullion, M., Láng, I., Wardley, A., Lichinitser, M., Sanchez, R. I. L., Müller, V., Dodwell, D., Gelber, R. D., Piccart-Gebhart, M. J. & Cameron, D., márc. 1 2013, In : The Lancet Oncology. 14, 3, p. 244-248 5 p.

Research output: Article

89 Citations (Scopus)

Cyclosporin A hatása emberi limfociták antitest-dependens és természetes citotoxicitására.

Láng, I., Chen, S. H. & Peter, L., máj. 15 1983, In : Orvosi hetilap. 124, 20, p. 1181-1183 3 p.

Research output: Article

Decreased antibody-dependent and spontaneous cell-mediated cytotoxicity in patients with chronic renal failure

Láng, I., Taraba, I. & Petrányi, G., nov. 1981, In : Immunology letters. 3, 5, p. 267-271 5 p.

Research output: Article

5 Citations (Scopus)

Demonstration of insulin neutralizing antibody with the aid of 125I insulin (Hungarian)

Lang, I., Stutzel, M., Littmann, L. & Balazsi, I., jan. 1 1974, In : Orvosi hetilap. 115, 4, p. 211-212 2 p.

Research output: Article

Depressed lectin-dependent cell-mediated cytotoxicity again HEP-2 cells in patients with metastasizing solid tumour

Perl, A., Gonzalez-Cabello, R., Lang, I. & Gergely, P., jan. 1 1985, In : Acta physiologica Hungarica. 65, 2, p. 149-153 5 p.

Research output: Article

Depressed lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells in patients with carcinoma of the uterine cervix

Perl, A., Gonzalez-Cabello, R., Láng, I., Somos, P. & Gergely, P., júl. 1 1983, In : Cancer Immunology Immunotherapy. 15, 2, p. 155-158 4 p.

Research output: Article

8 Citations (Scopus)

Depressed monocyte production of interleukin‐1 and tumor necrosis factor‐alpha in patients with alcoholic liver cirrhosis

Müzes, GY., Deák, GY., Láng, I., González‐Cabello, R., Gergely, P. & Fehér, J., okt. 1989, In : Liver. 9, 5, p. 302-306 5 p.

Research output: Article

21 Citations (Scopus)
6 Citations (Scopus)

Effect of (+cyanidanol-3 on cellular immune reactions and on superoxide dismutase activity in vitro

Láng, I., Nékám, K., Deák, G., Müzes, G., Gonzalez, C. R., Kádár, J., Perl, A., Gergely, P. & Fehér, J., jan. 1 1987, In : Free radical research. 4, 1, p. 51-60 10 p.

Research output: Article

2 Citations (Scopus)

Effect of changes in cyclic nucleotide levels on human antibody-dependent cellular cytotoxicity

Kalmar, L., Lang, I., Gergely, P., Fekete, B. & Petrányi, G., dec. 1 1978, In : Acta medica Academiae Scientiarum Hungaricae. 35, 1, p. 35-42 8 p.

Research output: Article

3 Citations (Scopus)
1 Citation (Scopus)
1 Citation (Scopus)

Effect of Fc receptor blocking on human natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells

Perl, A., Gonzalez-Cabello, R., Pócsik, É., Láng, I. & Gergely, P., jún. 1983, In : Immunology letters. 6, 6, p. 317-321 5 p.

Research output: Article

1 Citation (Scopus)

Effect of genetic predisposition on the risk of gallbladder cancer in Hungary

Kimura, A., Tsuchiya, Y., Lang, I., Zoltan, S., Nakadaira, H., Ajioka, Y., Kiyohara, C., Oyama, M., Nakamura, K. & Yamamoto, M., 2008, In : Asian Pacific Journal of Cancer Prevention. 9, 3, p. 391-396 6 p.

Research output: Article

15 Citations (Scopus)
4 Citations (Scopus)

Effect of Histamine Receptor Blocking on Human Antibody‐dependent Cell‐mediated Cytotoxicity

LÁNG, I., TÖRÖK, K., GERGELY, P., NÉKÁM, K. & PETRÁNYI, GY., ápr. 1981, In : Scandinavian Journal of Immunology. 13, 4, p. 361-366 6 p.

Research output: Article

8 Citations (Scopus)

Effect of histamine-receptor blocking on human natural and lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells

Perl, A., Gonzalez-Cabello, R., Benedek, K., Nékam, K., Láng, I. & Gergely, P., okt. 23 1985, In : Thymus. 7, 2, p. 111-118 8 p.

Research output: Article

Effect of histamine receptor inhibition on antibody-dependent cellular cytotoxicity

Lang, I., Torok, K. & Gergely, P., jan. 1 1980, In : Kiserletes Orvostudomany. 32, 6, p. 590-595 6 p.

Research output: Article

Effect of in vitro Aica-P treatment on certain cellular immune functions

Deak, G., Muzes, G., Lang, I., Nekam, K., Gonzalez-Cabello, R., Gergely, P. & Feher, J., dec. 1 1990, In : Acta physiologica Hungarica. 76, 2, p. 105-111 7 p.

Research output: Article

2 Citations (Scopus)
11 Citations (Scopus)
6 Citations (Scopus)
18 Citations (Scopus)
26 Citations (Scopus)

Effect of the transfer factor (TF) on human antibody-dependent cellular cytotoxicity (ADCC) in vitro

Lang, I., Nekam, K., Kalmar, L. & Petranyi, G., jan. 1 1979, In : Kiserletes Orvostudomany. 31, 3, p. 225-229 5 p.

Research output: Article